Attached files
| file | filename |
|---|---|
| 8-K/A - AMENDMENT TO CURRENT REPORT - MABVAX THERAPEUTICS HOLDINGS, INC. | mbvx8ka.htm |
Exhibit 16.1
May 21,
2018
Securities
and Exchange Commission
Washington,
D.C. 20549
Dear
Sirs:
We have
read the statements made by MabVax Therapeutics Holdings, Inc. in
Item 8.01 of its Current Report on Form 8-K. We agree with such
statements as they relate to our Firm. We have no basis to agree or
disagree with the other statements made therein.
Very
truly yours,
/s/
CohnReznick LLP